Appyea, Inc. Files Q1 2024 10-Q Report
Ticker: APYP · Form: 10-Q · Filed: May 20, 2024 · CIK: 1568969
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Appyea Q1 24 10-Q filed. Financials look steady.
AI Summary
Appyea, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and position for the first quarter of 2024, including balance sheet items and statements of operations. Specific financial figures and operational details for the quarter are presented within the report.
Why It Matters
This report provides investors and analysts with the latest financial performance data for Appyea, Inc., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new disclosures.
Key Numbers
- Q1 2024 — Reporting Period (Financial performance for the first quarter of 2024 is detailed.)
- 2024-03-31 — Balance Sheet Date (Financial position as of the end of the first quarter.)
- 2023-12-31 — Prior Period Balance Sheet Date (Comparison point for financial position.)
Key Players & Entities
- APPYEA, INC (company) — Filer
- 20240331 (date) — Period of Report
- 20240520 (date) — Filing Date
- 7371 (number) — Standard Industrial Classification
FAQ
What were Appyea, Inc.'s total revenues for the first quarter of 2024?
The filing does not explicitly state the total revenue figure in the provided text snippet, but it indicates that financial performance for the period ending March 31, 2024, is detailed.
What is Appyea, Inc.'s primary business activity?
Appyea, Inc. is classified under Standard Industrial Classification code 7371, which corresponds to Services-Computer Programming Services.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on May 20, 2024.
What is the fiscal year end for Appyea, Inc.?
Appyea, Inc.'s fiscal year ends on December 31.
What are the main components of Appyea, Inc.'s equity as of March 31, 2024?
The filing mentions components such as PreferredStock, CommonStock, AdditionalPaidInCapital, StockPayables, RetainedEarnings, Parent, and NoncontrollingInterest as of March 31, 2024.
Filing Stats: 4,677 words · 19 min read · ~16 pages · Grade level 13.9 · Accepted 2024-05-20 15:49:07
Key Financial Figures
- $0.0001 — he registrant's common stock, par value $0.0001 per share. APPYEA, INC. Form 10-Q
- $000 — e March 31, 2024 December 31, 2023 $000 Opening Balance, (including short ter
Filing Documents
- form10-q.htm (10-Q) — 637KB
- ex31-1.htm (EX-31.1) — 12KB
- ex31-2.htm (EX-31.2) — 12KB
- ex32-1.htm (EX-32.1) — 6KB
- ex32-2.htm (EX-32.2) — 7KB
- 0001493152-24-020652.txt ( ) — 3428KB
- apyp-20240331.xsd (EX-101.SCH) — 27KB
- apyp-20240331_cal.xml (EX-101.CAL) — 36KB
- apyp-20240331_def.xml (EX-101.DEF) — 107KB
- apyp-20240331_lab.xml (EX-101.LAB) — 257KB
- apyp-20240331_pre.xml (EX-101.PRE) — 200KB
- form10-q_htm.xml (XML) — 444KB
– Unaudited Condensed Consolidated Financial Statements
Item 1 – Unaudited Condensed Consolidated Financial Statements 4 Condensed Consolidated Balance Sheets – March 31, 2024 (unaudited) and December 31, 2022 5 Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (unaudited) 6 Condensed Consolidated Statement of Changes in Stockholders' Equity (deficit) for the three months ended March 31, 2024 and 2023 (unaudited) 7 Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (unaudited) 8 Notes to Unaudited Condensed Consolidated Financial Statements 9-16
– Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations 17
– Quantitative and Qualitative Disclosures About Market Risk
Item 3 – Quantitative and Qualitative Disclosures About Market Risk 23
– Controls and Procedures
Item 4 – Controls and Procedures 23
— OTHER INFORMATION
PART II — OTHER INFORMATION 24
– Legal Proceedings
Item 1 – Legal Proceedings 24
– Risk Factors
Item 1A – Risk Factors 25
– Unregistered Sales of Equity Securities and Use of Proceeds
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds 25
– Defaults upon Senior Securities
Item 3 – Defaults upon Senior Securities 25
– Mine Safety Disclosures
Item 4 – Mine Safety Disclosures 25
– Other Information
Item 5 – Other Information 25
– Exhibits
Item 6 – Exhibits 25 Exhibit Index 25
SIGNATURES
SIGNATURES 26 2 APPYEA INC. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2024 3 APPYEA INC. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2024 INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Page Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Operations 6 Condensed Consolidated Statements of Changes in Deficiency 7 Condensed Consolidated Statements of Cash Flows 8 Notes to the Condensed Consolidated Financial Statements 9-16 4 APPYEA INC. CONDENSED CONSOLIDATED BALANCE SHEETS (U.S. dollars in thousands) March 31, 2024 December 31, 2023 Unaudited Audited ASSETS Current assets Cash and cash equivalents 373 222 Accounts receivables 1 - Other accounts receivables 30 42 Inventory 14 14 Total current assets 418 278 Non-current assets Property and equipment, net 2 3 Intangible assets, net 238 193 Total non-current asset 240 196 Total assets 658 474 LIABILITIES AND DEFICIENCY Current liabilities Trade payables 24 51 Other accounts payable 679 694 Short-term loans from related party 79 79 Convertible loans at amortized cost 811 796 Convertible loans – At fair value 2,160 1,203 Financial liability at fair value 72 204 Total current liabilities 3,825 3,027 Total liabilities 3,825 3,027 DEFICIENCY AppYea Inc. Stockholders' Deficiency: Convertible preferred stock, $ 0.0001 par value - - Common stock, $ 0.0001 par value 41 31 Stock payables 657 559 Additional Paid in Capital 3,719 3,197 Accumulated deficit ( 7,570 ) ( 6,326 ) Total AppYea Inc. stockholders' deficiency ( 3,153 ) ( 2,539 ) Non-controlling interests ( 14 ) ( 14 ) Total Deficiency ( 3,167 ) ( 2,553 ) Total liabilities and deficiency 658 474 The accompanying notes are an integral part of the financial statements. 5 APPYEA INC. CONDENSED CONS